InsiderTradr

BioGaia AB (publ) (0GTN.IL)

IOB · SEK · Healthcare · Drug Manufacturers - Specialty & Generic

SEK 124.20 (-0.56%) as of

Key statistics

Market cap
12.88B
P/E (TTM)
30.15
EPS (TTM)
4.12
Dividend yield
1.48%
52-week range
96.30 – 136.20
Revenue (TTM)
1.27B
Profit margin
34.36%
Volume
7.02k

About BioGaia AB (publ)

BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylori–the gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Stockholm, Sweden
Employees
212

biogaia.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks